Panchsheel Organics [PANCHSHEEL] vs Sun Pharma Advanced [SPARC] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Panchsheel Organics Ltd. wins in 14 metrics, Sun Pharma Advanced Research Company Ltd. wins in 3 metrics, with 0 ties. Panchsheel Organics Ltd. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Panchsheel Organics Ltd. | Sun Pharma Advanced Research Company Ltd. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 13.32 | -13.65 | Panchsheel Organics Ltd. |
| Price-to-Book Ratio | 1.16 | -13.55 | Panchsheel Organics Ltd. |
| Debt-to-Equity Ratio | 2.87 | -1.21 | Panchsheel Organics Ltd. |
| PEG Ratio | N/A | -11.15 | N/A |
| EV/EBITDA | 10.98 | -22.27 | Panchsheel Organics Ltd. |
| Profit Margin (TTM) | 11.65% | -53.22% | Panchsheel Organics Ltd. |
| Operating Margin (TTM) | 11.91% | -700.71% | Panchsheel Organics Ltd. |
| EBITDA Margin (TTM) | 11.91% | N/A | N/A |
| Return on Equity | 10.31% | 157.88% | Sun Pharma Advanced Research Company Ltd. |
| Return on Assets (TTM) | 8.45% | -102.08% | Panchsheel Organics Ltd. |
| Free Cash Flow (TTM) | $-117.21M | $-3.71B | Panchsheel Organics Ltd. |
| Dividend Yield | 4.35% | N/A | N/A |
| 1-Year Return | -4.98% | 14.56% | Sun Pharma Advanced Research Company Ltd. |
| Price-to-Sales Ratio (TTM) | 1.55 | 87.98 | Panchsheel Organics Ltd. |
| Enterprise Value | $1.63B | $50.87B | Sun Pharma Advanced Research Company Ltd. |
| EV/Revenue Ratio | 1.57 | 95.73 | Panchsheel Organics Ltd. |
| Gross Profit Margin (TTM) | 34.38% | -59.53% | Panchsheel Organics Ltd. |
| Revenue per Share (TTM) | $78 | $2 | Panchsheel Organics Ltd. |
| Earnings per Share (Diluted) | $9.14 | $-8.25 | Panchsheel Organics Ltd. |
| Beta (Stock Volatility) | -0.30 | 0.19 | Panchsheel Organics Ltd. |
Panchsheel Organics Ltd. vs Sun Pharma Advanced Research Company Ltd. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Panchsheel Organics Ltd. | -1.30% | -15.43% | 6.51% | 18.60% | -9.81% | -5.54% |
| Sun Pharma Advanced Research Company Ltd. | 2.09% | -13.30% | 46.20% | 62.20% | 26.84% | 51.26% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Panchsheel Organics Ltd. | -4.98% | -18.00% | 43.64% | 114.77% | 747.06% | 5,333.96% |
| Sun Pharma Advanced Research Company Ltd. | 14.56% | 13.10% | -5.14% | -23.02% | 148.11% | -27.03% |
Performance & Financial Health Analysis: Panchsheel Organics Ltd. vs Sun Pharma Advanced Research Company Ltd.
| Metric | PANCHSHEEL | SPARC |
|---|---|---|
| Market Information | ||
| Market Cap | ₹1.54B | ₹46.75B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 3,902 | 2,401,062 |
| 90 Day Avg. Volume | 10,174 | 2,083,443 |
| Last Close | ₹121.15 | ₹208.50 |
| 52 Week Range | ₹86.10 - ₹184.00 | ₹108.00 - ₹248.75 |
| % from 52W High | -34.16% | -16.18% |
| All-Time High | ₹425.55 (Sep 05, 2022) | ₹875.00 (Apr 24, 2006) |
| % from All-Time High | -71.53% | -76.17% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.02% | -0.43% |
| Quarterly Earnings Growth | 0.00% | -0.43% |
| Financial Health | ||
| Profit Margin (TTM) | 0.12% | -0.53% |
| Operating Margin (TTM) | 0.12% | -7.01% |
| Return on Equity (TTM) | 0.10% | 1.58% |
| Debt to Equity (MRQ) | 2.87 | -1.21 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹105.06 | ₹-10.63 |
| Cash per Share (MRQ) | ₹2.86 | ₹0.03 |
| Operating Cash Flow (TTM) | ₹110.43M | ₹-3,484,287,000 |
| Levered Free Cash Flow (TTM) | ₹137.95M | ₹-3,425,094,000 |
| Dividends | ||
| Last 12-Month Dividend Yield | 4.35% | N/A |
| Last 12-Month Dividend | ₹4.80 | N/A |
Valuation & Enterprise Metrics Analysis: Panchsheel Organics Ltd. vs Sun Pharma Advanced Research Company Ltd.
| Metric | PANCHSHEEL (Apr 24, 2026) | SPARC (Apr 22, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 13.32 | -13.65 |
| Forward P/E | N/A | 2.60 |
| PEG Ratio | N/A | -11.15 |
| Price to Sales (TTM) | 1.55 | 87.98 |
| Price to Book (MRQ) | 1.16 | -13.55 |
| Market Capitalization | ||
| Market Capitalization | ₹1.54B | ₹46.75B |
| Enterprise Value | ₹1.63B | ₹50.87B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.57 | 95.73 |
| Enterprise to EBITDA | 10.98 | -22.27 |
| Risk & Other Metrics | ||
| Beta | -0.30 | 0.19 |
| Book Value per Share (MRQ) | ₹105.06 | ₹-10.63 |
Financial Statements Comparison: Panchsheel Organics Ltd. vs Sun Pharma Advanced Research Company Ltd.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | PANCHSHEEL (2025) | SPARC (2025) |
|---|---|---|
| Revenue/Sales | 1.07B | 717.66M |
| Cost of Goods Sold | 693.70M | 1.10B |
| COGS % of Revenue | 64.8% | 153.2% |
| Gross Profit | 377.22M | -381.94M |
| Gross Margin | 35.2% | -53.2% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | 154.03M | -3.34B |
| Operating Margin | 14.4% | -465.5% |
| EBITDA | 203.76M | -3.23B |
| EBITDA Margin | 19.0% | -450.0% |
| Pre-Tax Income | 180.97M | -3.43B |
| Pre-Tax Income % of Revenue | 16.9% | -477.6% |
| Income Tax | 43.03M | -2.72M |
| Income Tax % of Revenue | 4.0% | -0.4% |
| Net Income (Profit) | 137.95M | -3.43B |
| Profit Margin | 12.9% | -477.3% |
Balance Sheet & Liquidity Metrics
| Metric | PANCHSHEEL (2025) | SPARC (2025) |
|---|---|---|
| Cash & Equivalents | 41.52M | 19.64M |
| Total Current Assets | 887.29M | 261.97M |
| Total Current Assets % of Revenue | 82.9% | 36.5% |
| Total Current Liabilities | 242.76M | 3.74B |
| Total Current Liabilities % of Revenue | 22.7% | 521.5% |
| Long-Term Debt | 1.78M | 1.07B |
| Long-Term Debt % of Revenue | 0.2% | 149.0% |
| Total Shareholders Equity | 1.34B | -2.17B |
| Retained Earnings | 637.98M | -23.22B |
| Retained Earnings % of Revenue | 59.6% | -3,235.0% |
| Property, Plant & Equipment | 12.99M | 178.02M |
Cash Flow Statement Comparison
| Metric | PANCHSHEEL (2025) | SPARC (2025) |
|---|---|---|
| Operating Cash Flow | 110.43M | -3.48B |
| Operating Cash Flow % of Revenue | 10.3% | -485.5% |
| Capital Expenditures | -155.56M | -97.45M |
| Free Cash Flow | -117.21M | -3.71B |
| FCF Margin | -10.9% | -516.4% |
| Debt Repayment | -8.72M | -3.69B |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | PANCHSHEEL | SPARC |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 13.17M | 324.52M |
| Float Shares | 5.11M | 91.32M |
| % Held by Insiders | 61.26% | 72.96% |
| % Held by Institutions | 0.00% | 2.56% |
| % Held by Public | 38.74% | 24.48% |
Dividend Analysis & Yield Comparison: Panchsheel Organics Ltd. vs Sun Pharma Advanced Research Company Ltd.
| Metric | PANCHSHEEL | SPARC |
|---|---|---|
| Last 12-Month Dividend | ₹4.80 | N/A |
| Last 12-Month Dividend Yield | 4.35% | N/A |
| 3-Year Avg Annual Dividend | ₹4.00 | N/A |
| 3-Year Avg Dividend Yield | 0.45% | N/A |
| 3-Year Total Dividends | ₹12.00 | N/A |
| Ex-Dividend Date | Feb 20, 2026 | N/A |